Cheaper drugs, vaccines forecast as collaborations grow between developing countries’ biotech firms

McLaughlin-Rotman Centre for Global Health

10 May 2010

‘South-South’ biotech collaborations boost health, economies: Study

The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech firms in developing countries, according to a study to be published Mon. May 10 in the UK journalĀ Nature Biotechnology.

Researchers from five developing countries, together with colleagues at Canada’s McLaughlin-Rotman Centre for Global Health, interviewed over 300 experts in 13 developing countries to produce the first-ever large scale study of “south-south” collaboration in health-related biotechnology.

Full news release text, click here

Coverage summary, click here

Example coverage, by the DPA newswire, click here, by, click here